Matches in Nanopublications for { ?s ?p "[In this article entitled 'How many JAK inhibitors for myelofibrosis' we discuss JAK2 as a target, review briefly the benefits to patients with MF of JAK inhibition and highlight some of the differences between the number of JAK inhibitors currently being evaluated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- assertion description "[In this article entitled 'How many JAK inhibitors for myelofibrosis' we discuss JAK2 as a target, review briefly the benefits to patients with MF of JAK inhibition and highlight some of the differences between the number of JAK inhibitors currently being evaluated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In this article entitled 'How many JAK inhibitors for myelofibrosis' we discuss JAK2 as a target, review briefly the benefits to patients with MF of JAK inhibition and highlight some of the differences between the number of JAK inhibitors currently being evaluated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.